These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35884481)

  • 21. Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome-A Taiwan Cancer Registry national database analysis.
    Cheng YJ; Tsai MH; Chiang CJ; Tsai ST; Liu TW; Lou PJ; Liao CT; Lin JC; Chang JT; Tsai MH; Chu PY; Leu YS; Tsai KY; Terng SD; Chien CY; Yang MH; Hao SP; Wang CC; Tsai MH; Chen HHW; Kuo C; Wu YH
    Cancer Med; 2018 Jul; 7(7):3073-3083. PubMed ID: 29905028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of Early Recurrence Prior to Planned Postoperative Radiation Therapy for Oral Cavity Squamous Cell Carcinoma and Outcomes Following Salvage Intensified Radiation Therapy.
    Hosni A; Huang SH; Chiu K; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; O'Sullivan B; Ringash J; Waldron J; Spreafico A; Yu E; de Almeida JR; Monteiro E; Chepeha DB; Irish JC; Goldstein DP; Hope A
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):363-373. PubMed ID: 30244160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II receptor blockers and oral squamous cell carcinoma survival: A propensity-score-matched cohort study.
    Wu CN; Wu SC; Chen WC; Yang YH; Chin JC; Chien CY; Fang FM; Li SH; Luo SD; Chiu TJ
    PLoS One; 2021; 16(12):e0260772. PubMed ID: 34855858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin Use Ameliorates Survival in Oral Squamous Cell Carcinoma-Data from a Population-Based Cohort Study Applying Propensity Score Matching.
    Spoerl S; Gerken M; Fischer R; Spoerl S; Kirschneck C; Wolf S; Taxis J; Ludwig N; Biermann N; Reichert TE; Spanier G
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction chemotherapy for squamous cell carcinomas of the oral cavity: A cumulative meta-analysis.
    Lau A; Li KY; Yang WF; Su YX
    Oral Oncol; 2016 Oct; 61():104-14. PubMed ID: 27688112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant Whole Breast Radiotherapy Improve Survival in Women with Heart Failure with Reduced Ejection Fraction Receiving Breast-Conserving Surgery.
    Zhang J; Sum SY; Hsu JG; Chiang MF; Lee TS; Wu SY
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of glycated hemoglobin A1c on the survival of patients with oral squamous cell carcinoma: A multi-institutional database cohort study.
    Chao CY; Luo SD; Chen WC; Wu SC; Chiu TJ; Wang YM; Yang YH; Fang FM; Li SH; Li CY; Wu CN
    Front Oncol; 2022; 12():952616. PubMed ID: 36106112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distant Metastases Following Postoperative Intensity-Modulated Radiotherapy for Oral Cavity Squamous Cell Carcinoma.
    Hosni A; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; De Almeidad J; O'Sullivan B; Goldstein D; Hope A
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):368-375. PubMed ID: 28033442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COL11A1 as a potential prognostic target for oral squamous cell carcinoma.
    Di YB; Bao Y; Guo J; Liu W; Zhang SX; Zhang GH; Li TK
    Medicine (Baltimore); 2022 Oct; 101(40):e30989. PubMed ID: 36221427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC.
    Grimm M
    Clin Transl Oncol; 2012 Nov; 14(11):870-80. PubMed ID: 22855158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of continuity of care on the postradiotherapy survival of working-age patients with oral cavity cancer: A nationwide population-based cohort study in Taiwan.
    Kuo TJ; Wu PC; Tang PL; Yin CH; Chu CH; Hung YM
    PLoS One; 2019; 14(12):e0225635. PubMed ID: 31841525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of nodal skip metastasis in patients with mid-thoracic oesophageal squamous cell carcinoma: a propensity score matching study.
    Xu ZJ; Zhuo ZG; Song TN; Alai GH; Shen X; Yao P; Lin YD
    Eur J Cardiothorac Surg; 2021 Apr; 59(4):799-806. PubMed ID: 33249483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A biomarker-based prediction model for risk of locoregional recurrence in pathologic stage IIIA-N2 non-small cell lung cancer.
    Jiang G; Huang J; Cui T; Lin X; Lin G
    Int J Clin Exp Pathol; 2020; 13(12):3060-3082. PubMed ID: 33425107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
    Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
    Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma.
    Liao CT; Chen HN; Wen YW; Lee SR; Ng SH; Liu TW; Tsai ST; Tsai MH; Lin JC; Lou PJ; Wang CP; Chu PY; Leu YS; Tsai KY; Terng SD; Chen TM; Wang CH; Chien CY; Chen WC; Lee LY; Lin CY; Wang HM; Lin CH; Fang TJ; Huang SF; Kang CJ; Chang KP; Yang LY; Yen TC
    Eur J Cancer; 2017 Feb; 72():226-234. PubMed ID: 28056426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study.
    Tsai CY; Wen YW; Lee SR; Ng SH; Kang CJ; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
    BMC Cancer; 2023 Feb; 23(1):126. PubMed ID: 36750965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of survival factors of oral squamous cell carcinoma].
    Huang JF; Wang JW; He BC; Chen F; Liu FP; Yan LJ; Wu JF; Wang SH; Peng XQ; Huang SW; Wang XP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Oct; 50(10):880-886. PubMed ID: 27686766
    [No Abstract]   [Full Text] [Related]  

  • 39. Paravertebral block in regional anesthesia with propofol sedation reduces locoregional recurrence in patients with breast cancer receiving breast conservative surgery compared with volatile inhalational without propofol in general anesthesia.
    Zhang J; Chang CL; Lu CY; Chen HM; Wu SY
    Biomed Pharmacother; 2021 Oct; 142():111991. PubMed ID: 34449311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
    Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
    BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.